Percutaneous Coronary Intervention (PCI) Devices Market

Market Insights

Percutaneous coronary intervention (PCI) is a non-surgical procedure utilized to treat coronary artery disease. A balloon catheter and coronary stents are used to remove the plaque and treat the narrowing of blood vessels. In a PCI procedure, a coronary guidewire is used to direct the balloon catheter to the site of the plaque in the coronary artery. A balloon catheter is thereafter inserted into the coronary artery of the heart and inflated at the site of the plaque. Generally, a stent is placed at that site to mitigate the risk of restenosis at the treatment site. The global percutaneous coronary intervention devices market is expected to grow in the forecast period owing to the rise in the incidence of heart diseases, diabetes, and coronary artery disease. Further development of advanced technologies for PCI procedures leads to the growth of the market.

This report studies the market for various devices used in PCI procedures and consists of the latest analysis of the global percutaneous coronary intervention devices market through extensive primary and secondary research. A comprehensive understanding of the global market is provided in the report based on quantitative and qualitative research. This report aids the market stakeholders in taking informed initiatives in the global percutaneous coronary intervention devices market.

For the analysis, the global percutaneous coronary intervention devices market is categorized based on device type, usage areas, and geographical demarcation. On the basis of device type, the global percutaneous coronary intervention devices market is categorized into coronary stents, PTCA catheters, and coronary guidewires. On the basis of usage areas, the global percutaneous coronary intervention devices market is categorized into hospitals, ambulatory surgical centers, and catheterization labs. The analysis of the global market for percutaneous coronary intervention devices is performed in terms of market size for the period 2016–2026, considering 2017 as the base year and 2018–2026 as the forecast period. The CAGRs of each of the aforementioned segments are calculated for the forecast period.

Based on geographical demarcation, the global percutaneous coronary intervention devices market is analyzed by categorizing the market into five major regions as follows:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • Italy
  • U.K.
  • Russia
  • Rest of Europe
• Asia-Pacific
  • India
  • China
  • Japan
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

On the basis of geographical demarcation, the market size of the global percutaneous coronary intervention devices market is presented for the period 2016–2026, and CAGRs are calculated for the forecast period. Further, geographical regions are analyzed by sub-segmenting them in terms of device type, end-user, and constituent countries.

Major qualitative market assessment factors are incorporated in the report, including key market insights, market trends and dynamics, product launches, and opportunities. The competitive landscape of major players is provided in a graphical format based on market share, product portfolio, and improvement opportunities. This report also constitutes Porter’s five forces model for the proper understanding of the global percutaneous coronary intervention devices market. Major players profiled in this report include Abbott Laboratories, Inc., Boston Scientific Corporation, Biotronik SE & Co. KG, B. Braun Melsungen AG, Biosensors International Group, Getinge AB, Johnson & Johnson, Medtronic plc, St. Jude Medical, and Terumo Corporation.

For the purpose of this study, the global market for percutaneous coronary intervention devices is studied by the following device types:

• Coronary Stents
• PTCA Catheters
• Coronary Guidewires

A percutaneous coronary intervention procedure is performed to treat coronary artery disease by removing the plaque from the coronary arteries. Coronary guidewires are used to direct the PTCA catheters to the site of the plaque, and thereafter, catheters are employed for plaque removal. This is followed by stent placement at the site of the plaque to prevent restenosis.

In terms of market value, the PTCA catheter segment leads the global percutaneous coronary intervention devices market for the year 2017 due to the increased adoption of PCI procedures over conventional treatment methods; the non-invasive and safer approach of PCI mainly contributes to this shift. In addition, technological advancements in the nature and material of stents will make this segment grow at the fastest CAGR. Greater prices of stents and their incumbent role in the prevention of restenosis mainly drive the growth of this segment.

For the purpose of this study, the global market for percutaneous coronary intervention devices is studied for their application in the following usage areas:

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Catheterization Labs

Percutaneous coronary intervention (PCI) procedures are adopted across the world for the treatment of coronary heart disease. PCI is a minimally invasive procedure and thereby potentially reduces the risk of post-treatment complications and infections. In terms of market value, hospitals led the global percutaneous coronary intervention devices market for the year 2017 due to the availability of skilled professionals required for the PCI procedure.

Furthermore, the availability of favorable reimbursements in hospitals and devices that aid in minimally invasive techniques, such as robotic devices, favors the prominent position of the hospital segment. However, with the increase in the number of cases for PCI procedures, the population is turning towards catheterization labs for treatment due to the quick turnaround time.Based on geographical regions, the global percutaneous coronary intervention devices market is segmented into North America, Latin America, Asia Pacific, Europe, and the Middle East and Africa.

As per the research, North America dominated the global percutaneous coronary intervention devices market in 2017 and is projected to retain its lead in the market throughout the forecast period. The adoption of PCI procedures, improved healthcare services, and the high incidence of coronary artery disease in the region contribute to its dominance. The global percutaneous coronary intervention devices market in North America is expected to grow further due to supportive government initiatives and favorable reimbursement policies.

According to the CDC, coronary artery disease is the most common type of heart disease, killing over 370,000 individuals annually. Further, Asia Pacific is anticipated to experience the fastest market growth during the forecast years. This regional growth is anticipated due to the increasing prevalence of heart diseases, rising healthcare facilities, and increased awareness of heart diseases among the general population.

The detailed regional classification of the global percutaneous coronary intervention market is as follows:

• North America
• North American Percutaneous Coronary Intervention Devices Market, by Device Type, 2016–2026 (US$ Mn)
• North American percutaneous coronary intervention devices market, by end-user, 2016–2026 (US$ Mn)
• North America Percutaneous Coronary Intervention Devices Market, by Country, 2016–2026 (US$ Mn)
• U.S.
• Canada
• Europe
• Europe Percutaneous Coronary Intervention Devices Market, by Device Type, 2016–2026 (US$ Mn)
• Europe Percutaneous Coronary Intervention Devices Market, by End-User, 2016–2026 (US$ Mn)
• Europe Percutaneous Coronary Intervention Devices Market, by Country, 2016–2026 (US$ Mn)
• U.K.
• Germany
• Rest of Europe
• Asia Pacific
• Asia Pacific Percutaneous Coronary Intervention Devices Market, by Device Type, 2016–2026 (US$ Mn)
• Asia Pacific Percutaneous Coronary Intervention Devices Market, by End-User, 2016–2026 (US$ Mn)
• Asia Pacific Percutaneous Coronary Intervention Devices Market, by Country, 2016–2026 (US$ Mn)
• China
• Japan
• Rest of Asia Pacific
• Latin America
• Latin America Percutaneous Coronary Intervention Devices Market, by Device Type, 2016–2026 (US$ Mn)
• Latin America Percutaneous Coronary Intervention Devices Market, by End-User, 2016–2026 (US$ Mn)
• Latin America Percutaneous Coronary Intervention Devices Market, by Country, 2016–2026 (US$ Mn)
• Brazil
• Mexico
• rest of Latin America
• Middle East and Africa (MEA)
• Middle East and Africa Percutaneous Coronary Intervention Devices Market, by Device Type, 2016–2026 (US$ Mn)
• Middle East and Africa Percutaneous Coronary Intervention Devices Market, by End-User, 2016–2026 (US$ Mn)
• Middle East and Africa Percutaneous Coronary Intervention Devices Market, by Country, 2016–2026 (US$ Mn)
• GCC
• Rest of the Middle East and Africa

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Percutaneous Coronary Intervention Devices Market Portraiture
2.1.1. Global Percutaneous Coronary Intervention Devices Market, by Device Type, 2017 (US$ Bn)
2.1.2. Global Percutaneous Coronary Intervention Devices Market, by End-user, 2017 (US$ Bn)
2.1.3. Global Percutaneous Coronary Intervention Devices Market, by Geography, 2017 (US$ Bn)

Chapter 3. Percutaneous Coronary Intervention Devices Market: Market Dynamics and Outlook
3.1. Market Definition and Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography
3.6. Value Chain Analysis
3.7. Porter’s Five Forces Model
3.8. Competitive Landscape
3.8.1. Competitive Landscape, by Key Players, 2017

Chapter 4. Percutaneous Coronary Intervention Devices Market, by Device Type, 2016 – 2026 (US$ Bn)
4.1. Overview
4.1.1. Attractive Investment Proposition, by Device Type, 2017
4.2. Coronary Stents
4.3. PTCA Catheters
4.4. Coronary Guidewires

Chapter 5. Percutaneous Coronary Intervention Devices Market, by End-user, 2016 – 2026 (US$ Bn)
5.1. Overview
5.1.1. Comparative Analysis: Global Percutaneous Coronary Intervention Devices Market, by End-user, 2017 Vs 2026 (Value %)
5.2. Hospitals
5.3. Ambulatory Surgical Centers (ASCs)
5.4. Catheterization Labs

Chapter 6. Percutaneous Coronary Intervention Devices Market, by Geography, 2016 – 2026 (US$ Bn)
6.1. Overview
6.2. North America Percutaneous Coronary Intervention Devices Market Analysis, 2016 – 2026 (US$ Bn)
6.2.1. North America Percutaneous Coronary Intervention Devices Market, by Device Type, 2016 – 2026 (US$ Bn)
6.2.2. North America Percutaneous Coronary Intervention Devices Market, by End-user, 2016 – 2026 (US$ Bn)
6.2.3. North America Percutaneous Coronary Intervention Devices Market, by Country, 2016 – 2026 (US$ Bn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Percutaneous Coronary Intervention Devices Market Analysis, 2016 – 2026 (US$ Bn)
6.3.1. Europe Percutaneous Coronary Intervention Devices Market, by Device Type, 2016 – 2026 (US$ Bn)
6.3.2. Europe Percutaneous Coronary Intervention Devices Market, by End-user, 2016 – 2026 (US$ Bn)
6.3.3. Europe Percutaneous Coronary Intervention Devices Market, by Country, 2016 – 2026 (US$ Bn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific Percutaneous Coronary Intervention Devices Market Analysis, 2016 – 2026 (US$ Bn)
6.4.1. Asia Pacific Percutaneous Coronary Intervention Devices Market, by Device Type, 2016 – 2026 (US$ Bn)
6.4.2. Asia Pacific Percutaneous Coronary Intervention Devices Market, by End-user, 2016 – 2026 (US$ Bn)
6.4.3. Asia Pacific Percutaneous Coronary Intervention Devices Market, by Country, 2016 – 2026 (US$ Bn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. Rest of APAC
6.5. Latin America Percutaneous Coronary Intervention Devices Market Analysis, 2016 – 2026 (US$ Bn)
6.5.1. Latin America Percutaneous Coronary Intervention Devices Market, by Device Type, 2016 – 2026 (US$ Bn)
6.5.2. Latin America Percutaneous Coronary Intervention Devices Market, by End-user, 2016 – 2026 (US$ Bn)
6.5.3. Latin America Percutaneous Coronary Intervention Devices Market, by Country, 2016 – 2026 (US$ Bn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) Percutaneous Coronary Intervention Devices Market Analysis, 2016 – 2026 (US$ Bn)
6.6.1. MEA Percutaneous Coronary Intervention Devices Market, by Device Type, 2016 – 2026 (US$ Bn)
6.6.2. MEA Percutaneous Coronary Intervention Devices Market, by End-user, 2016 – 2026 (US$ Bn)
6.6.3. MEA Percutaneous Coronary Intervention Devices Market, by Region, 2016 – 2026 (US$ Bn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Company Profiles
7.1. Abbott Laboratories
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Application Portfolio
7.1.4. Key Developments
7.2. B. Braun Melsungen AG
7.3. Biosensors International Group
7.4. Biotronik SE & Co. KG
7.5. Boston Scientific Corporation
7.6. Getinge AB
7.7. Johnson & Johnson
7.8. Medtronic plc
7.9. St. Jude Medical.
7.10. Terumo Corporation

List of Figures

FIG. 1 Percutaneous Coronary Intervention: Market Segmentation
FIG. 2 Global Percutaneous Coronary Intervention Devices Market, by Device Type, 2017 (US$ Bn)
FIG. 3 Global Percutaneous Coronary Intervention Devices Market, by End-user, 2017 (US$ Bn)
FIG. 4 Global Percutaneous Coronary Intervention Devices Market, by Geography, 2017 (Value %)
FIG. 5 Attractive Investment Proposition, by Geography
FIG. 6 Market Competition Landscape, by Key Players, 2017
FIG. 7 Global Coronary Stents Market, 2016 – 2026 (US$ Bn)
FIG. 8 Global PTCA Catheters Market, 2016 – 2026 (US$ Bn)
FIG. 9 Global Coronary Guidewires Market, 2016 – 2026 (US$ Bn)
FIG. 10 Global PCI Market in Hospitals, 2016 – 2026 (US$ Bn)
FIG. 11 Global PCI Market in Ambulatory Surgical Centers, 2016 – 2026 (US$ Bn)
FIG. 12 Global PCI Market in Catheterization Labs, 2016 – 2026 (US$ Bn)
FIG. 13 U.S. Percutaneous Coronary Intervention Devices Market, 2016 – 2026 (US$ Bn)
FIG. 14 Canada Percutaneous Coronary Intervention Devices Market, 2016 – 2026 (US$ Bn)
FIG. 15 U.K. Percutaneous Coronary Intervention Devices Market, 2016 – 2026 (US$ Bn)
FIG. 16 Germany Percutaneous Coronary Intervention Devices Market, 2016 – 2026 (US$ Bn)
FIG. 17 Rest of Europe Percutaneous Coronary Intervention Devices Market, 2016 – 2026 (US$ Bn)
FIG. 18 Japan Percutaneous Coronary Intervention Devices Market, 2016 – 2026 (US$ Bn)
FIG. 19 China Percutaneous Coronary Intervention Devices Market, 2016 – 2026 (US$ Bn)
FIG. 20 Rest of Asia Pacific Percutaneous Coronary Intervention Devices Market, 2016 – 2026 (US$ Bn)
FIG. 21 Brazil Percutaneous Coronary Intervention Devices Market, 2016 – 2026 (US$ Bn)
FIG. 22 Mexico Percutaneous Coronary Intervention Devices Market, 2016 – 2026 (US$ Bn)
FIG. 23 Rest of Latin America Percutaneous Coronary Intervention Devices Market, 2016 – 2026 (US$ Bn)
FIG. 24 GCC Percutaneous Coronary Intervention Devices Market, 2016 – 2026 (US$ Bn)
FIG. 25 Rest of Middle East and Africa Percutaneous Coronary Intervention Devices Market, 2016 – 2026 (US$ Bn)

List of Tables

TABLE 1 Global Percutaneous Coronary Intervention Devices Market Portraiture
TABLE 2 Global Percutaneous Coronary Intervention Devices Market, by Device Type, 2016 – 2026 (US$ Bn)
TABLE 3 Global Percutaneous Coronary Intervention Devices Market, by End-user, 2016 – 2026 (US$ Bn)
TABLE 4 Global Percutaneous Coronary Intervention Devices Market, by Geography, 2016 – 2026 (US$ Bn)
TABLE 5 North America Percutaneous Coronary Intervention Devices Market, by Device Type, 2016 – 2026 (US$ Bn)
TABLE 6 North America Percutaneous Coronary Intervention Devices Market, by End-user, 2016 – 2026 (US$ Bn)
TABLE 7 North America Percutaneous Coronary Intervention Devices Market, by Country, 2016 – 2026 (US$ Bn)
TABLE 8 Europe Percutaneous Coronary Intervention Devices Market, by Device Type, 2016 – 2026 (US$ Bn)
TABLE 9 Europe Percutaneous Coronary Intervention Devices Market, by End-user, 2016 – 2026 (US$ Bn)
TABLE 10 Europe Percutaneous Coronary Intervention Devices Market, by Country, 2016 – 2026 (US$ Bn)
TABLE 11 Asia Pacific Percutaneous Coronary Intervention Devices Market, by Device Type, 2016 – 2026 (US$ Bn)
TABLE 12 Asia Pacific Percutaneous Coronary Intervention Devices Market, by End-user, 2016 – 2026 (US$ Bn)
TABLE 13 Asia Pacific Percutaneous Coronary Intervention Devices Market, by Country, 2016 – 2026 (US$ Bn)
TABLE 14 Latin America Percutaneous Coronary Intervention Devices Market, by Device Type, 2016 – 2026 (US$ Bn)
TABLE 15 Latin America Percutaneous Coronary Intervention Devices Market, by End-user, 2016 – 2026 (US$ Bn)
TABLE 16 Latin America Percutaneous Coronary Intervention Devices Market, by Country, 2016 – 2026 (US$ Bn)
TABLE 17 Middle East and Africa Percutaneous Coronary Intervention Devices Market, by Device Type, 2016 – 2026 (US$ Bn)
TABLE 18 Middle East and Africa Percutaneous Coronary Intervention Devices Market, by End-user, 2016 – 2026 (US$ Bn)
TABLE 19 Middle East and Africa Percutaneous Coronary Intervention Devices Market, by Country, 2016 – 2026 (US$ Bn)
TABLE 20 Abbott Laboratories: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 21 B. Braun Melsungen AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 22 Biosensors International Group: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 23 Biotronik SE & Co. KG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 24 Boston Scientific Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 25 Getinge AB: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 26 Johnson & Johnson: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 Medtronic plc: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 28 St. Jude Medical: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 29 Terumo Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)